SUMMARY The polymorphonuclear leucocyte (PMN) response to a chemotactic or chemokinetic stimulus is enhanced in men with ankylosing spondylitis (AS). This effect does not parallel the severity of disease activity or the size of the acute phase response, and it is independent of nonsteroidal anti-inflammatory drug treatment. Polymorph function is normal in HLA-B27 positive brothers of probands with AS and in other HLA-B27 positive individuals in the absence of disease. Polymorph motility is also normal in patients with psoriasis vulgaris or Crohn's disease, indicating that enhanced PMN motility is not a non-specific consequence of all inflammatory disorders.
Healthy individuals with HLA-B27 are more likely to develop ankylosing spondylitis (AS) than B27 negative subjects and are also prone to develop a reactive arthritis after exposure to certain bacteria.
The fundamental mechanisms involved for susceptibility to these disorders are unknown.
Previously, it has been reported that the polymorphonuclear leucocyte (PMN) response to certain chemotactic substances is enhanced in men with AS,1 2 HLA-B27 positive men with yersinia arthritis,3 and in healthy HLA-B27 positive controls. l-3
Thus polymorphs from HLA-B27 positive individuals may inherit an enhanced ability to respond to certain chemotactic stimuli. It has been proposed that such hyperresponsive PMNs would accumulate in large numbers at sites of inflammation and may be responsible for an excessive inflammatory response.5 Clinically, patients with either yersinia arthritis or sexually acquired reactive arthritis tend to have more severe disease if they are HLA-B27 positive. 6 7 The situation is less clear with AS because of the difficulty in recognition and diagnosis of mild cases, but it is known that acute uveitis occurs less frequently in patients with AS who do not have B27. The purpose of this study was to investigate further the relation between PMN migration, HLA-B27, and AS. 
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Subjects and methods
PATIENTS AND CONTROLS
Forty men with classical AS were investigated. Thirty seven were HLA-B27 positive, three B27 negative. Their ages ranged from 22 to 72 years (mean 43-5) and duration of disease ranged from three to 52 years (mean 19) . Drug treatment was not discontinued before the investigation. At the time of testing no patient or control had symptoms or signs of an acute bacterial or viral infection.
Seventeen men with AS attending an outpatient clinic at Westminster Hospital had healthy brothers willing to participate. All of the probands and 10 of the 17 brothers were B27 positive. The probands and controls were examined, and the ranges of chest expansion and spinal movement recorded. Three of the probands with AS had HLA identical brothers, two of whom on examination were proved to have AS. Thus these two pairs were analysed separately. The remaining 15 healthy brothers had no symptoms to suggest AS or uveitis, and examination was normal. An x ray examination of the spine was not performed routinely. Two brothers had been x rayed previously; the films were reviewed and found to be normal. The mean age of the probands was 43 years (range 22-61) and of the healthy brothers 43 years the brothers were Hb 135-178 g/l (mean 158 g/l), ESR 1-6 mm/h (mean 2 mm/h), CRP-all values below 6 mg/l. Ten healthy HLA-B27 positive individuals with neither history nor signs of AS or family history of AS were used as an additional control group for the brother study.
The B27 negative controls were members of staff of St Stephen's and Westminster Hospitals. They were selected using the following criteria: male, aged between 20 and 60 years, no joint disease, no family history of AS, and no current drug treatment. All subjects were tissue typed, and only those without HLA-B27 were included in the investigation.
DISEASE ACTIVITY
Each subject's disease activity was assessed at every visit. The amount of back pain was recorded on a four point scale; peripheral joint involvement was noted and graded on a similar scale; the duration of early morning stiffness was recorded in minutes; and the need for drug treatment and its effectiveness were recorded. From this data, and from previous knowledge of the patient, the activity of disease was classified in three groups: 1. Active-Significant trunk pain or active peripheral arthritis with morning stiffness in excess of one hour. Regular drug treatment required. 2. Probably active-Patients in whom an acute episode had settled incompletely or in whom significant morning stiffness worsened if drug treatment was discontinued. Retrospectively, the agarose plate results for each patient with AS were matched with their CRP results obtained on the same day. This enabled us to compared the PMN response to FMLP from 10 patients with active AS and high CRP concentrations and 10 patients with inactive AS and normal CRP concentrations. No correlation could be observed between the CRP concentration and PMN reponses to FMLP (data not illustrated).
POLYMORPH MOTILITY IN RELATION TO DRUG TREATMENT
To assess whether non-steroidal anti-inflammatory drugs taken orally could influence PMN motility in vitro PMN migration was measured using the agarose plate technique before and immediately after a two week course of naproxen (500 mg twice a day) in 11 men with AS. No drugs, except paracetamol, were permitted for one week before the drug trial. In men with AS both unstimulated and (Fig. 4) .
Discussion
This study has shown that the PMN response to two chemotactic substances is enhanced in men with AS.
In contrast with earlier reports,i-3 this exaggerated N-formyl-methionyl-leucyl-phenylalanine (FMLP) was used as the chemoattractant.
group of unrelated healthy B27 positive people. This PMN response was independent of disease activity, unrelated to the size of the acute phase response, and unaffected by non-steroidal anti-inflammatory drug consumption. In both this and our earlier studies' 2 the PMN respnse to a chemotactic sub- In a uniform concentration of FMLP the PMNs from patients with AS or from controls responded in an identical fashion to all the concentrations tested (Fig. 4 ). Yet, under the same experimental conditions on the same 96 well plate marked differences in migration were observed in response to ZAS. Even at low concentrations of ZAS the AS PMNs were more motile than those of the controls (Fig. 3) 
